Jim Simons

Jim Simons Renaissance Technologies

AUM $75.8B
1-Year Est. Return 50.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Quarter Est. Return
1 Year Est. Return
+50.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.71%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALEC icon
1851
Alector
ALEC
$155M
$2.81M ﹤0.01%
949,150
-305,700
WCC icon
1852
WESCO International
WCC
$12.6B
$2.81M ﹤0.01%
13,274
-134,100
HBNC icon
1853
Horizon Bancorp
HBNC
$945M
$2.8M ﹤0.01%
174,581
-27,635
NWBI icon
1854
Northwest Bancshares
NWBI
$1.87B
$2.79M ﹤0.01%
225,241
+22,542
MLKN icon
1855
MillerKnoll
MLKN
$1.14B
$2.79M ﹤0.01%
157,083
-65,700
OII icon
1856
Oceaneering
OII
$2.58B
$2.78M ﹤0.01%
112,300
+26,700
VOXR
1857
Vox Royalty Corp
VOXR
$364M
$2.78M ﹤0.01%
646,600
+103,492
ABEO icon
1858
Abeona Therapeutics
ABEO
$275M
$2.78M ﹤0.01%
526,437
+226,500
LRMR icon
1859
Larimar Therapeutics
LRMR
$336M
$2.77M ﹤0.01%
858,642
+296,900
DFAC icon
1860
Dimensional US Core Equity 2 ETF
DFAC
$40B
$2.77M ﹤0.01%
71,900
+7,100
INFA
1861
DELISTED
Informatica
INFA
$2.77M ﹤0.01%
+111,500
YINN icon
1862
Direxion Daily FTSE China Bull 3X Shares
YINN
$804M
$2.77M ﹤0.01%
+51,000
CTKB icon
1863
Cytek Biosciences
CTKB
$593M
$2.76M ﹤0.01%
795,544
-267,595
DYNF icon
1864
BlackRock US Equity Factor Rotation ETF
DYNF
$30.4B
$2.76M ﹤0.01%
46,600
-60,600
DCTH icon
1865
Delcath Systems
DCTH
$356M
$2.75M ﹤0.01%
256,200
+78,200
EML icon
1866
Eastern Company
EML
$119M
$2.74M ﹤0.01%
116,636
+1,499
NHTC icon
1867
Natural Health Trends
NHTC
$37.1M
$2.73M ﹤0.01%
611,315
-10,100
CULP icon
1868
Culp
CULP
$46.8M
$2.73M ﹤0.01%
612,917
-1,200
SSTK icon
1869
Shutterstock
SSTK
$668M
$2.73M ﹤0.01%
131,001
+69,900
SPRO icon
1870
Spero Therapeutics
SPRO
$129M
$2.73M ﹤0.01%
1,452,765
+620,600
TKC icon
1871
Turkcell
TKC
$5.32B
$2.73M ﹤0.01%
453,185
+88,285
FDMT icon
1872
4D Molecular Therapeutics
FDMT
$626M
$2.72M ﹤0.01%
313,186
+196,633
DH icon
1873
Definitive Healthcare
DH
$238M
$2.72M ﹤0.01%
670,240
-33,191
TNYA icon
1874
Tenaya Therapeutics
TNYA
$133M
$2.72M ﹤0.01%
1,678,202
-165,677
RUSHA icon
1875
Rush Enterprises Class A
RUSHA
$4.38B
$2.72M ﹤0.01%
50,800
-21,700